Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 6 | 2018 | 386 | 2.22 | Why? |
| HIV Antibodies | 8 | 2018 | 776 | 1.87 | Why? |
| HIV Envelope Protein gp120 | 5 | 2018 | 267 | 1.55 | Why? |
| HIV-1 | 10 | 2018 | 3365 | 1.42 | Why? |
| CD4 Antigens | 2 | 2018 | 306 | 1.32 | Why? |
| Antibodies, Neutralizing | 23 | 2021 | 25288 | 1.08 | Why? |
| HIV Envelope Protein gp41 | 3 | 2018 | 153 | 1.00 | Why? |
| Imaging, Three-Dimensional | 2 | 2017 | 680 | 0.92 | Why? |
| Hepatitis C Antibodies | 2 | 2018 | 120 | 0.90 | Why? |
| Immunoglobulin Fab Fragments | 3 | 2020 | 556 | 0.90 | Why? |
| Electron Microscope Tomography | 3 | 2020 | 167 | 0.87 | Why? |
| Polysaccharides | 2 | 2018 | 854 | 0.81 | Why? |
| Viral Hepatitis Vaccines | 1 | 2018 | 58 | 0.75 | Why? |
| Fluorescent Antibody Technique | 3 | 2021 | 835 | 0.72 | Why? |
| Mannose | 1 | 2017 | 68 | 0.68 | Why? |
| Secretory Component | 1 | 2016 | 1 | 0.67 | Why? |
| Receptors, Polymeric Immunoglobulin | 1 | 2016 | 19 | 0.66 | Why? |
| Epitopes | 9 | 2021 | 4113 | 0.64 | Why? |
| Cryoelectron Microscopy | 8 | 2021 | 2372 | 0.56 | Why? |
| Receptors, Fc | 2 | 2006 | 153 | 0.55 | Why? |
| Hepacivirus | 2 | 2018 | 1509 | 0.47 | Why? |
| Models, Molecular | 9 | 2021 | 7616 | 0.44 | Why? |
| Chickens | 1 | 2016 | 1010 | 0.42 | Why? |
| Hepatitis C | 2 | 2018 | 1514 | 0.41 | Why? |
| Receptors, Antigen, B-Cell | 2 | 2021 | 424 | 0.41 | Why? |
| Spike Glycoprotein, Coronavirus | 13 | 2021 | 37182 | 0.39 | Why? |
| Immunoglobulin G | 9 | 2021 | 21571 | 0.38 | Why? |
| Cricetulus | 4 | 2018 | 936 | 0.37 | Why? |
| Nanoparticles | 1 | 2021 | 2040 | 0.37 | Why? |
| HIV Infections | 7 | 2018 | 11620 | 0.34 | Why? |
| CHO Cells | 3 | 2018 | 831 | 0.34 | Why? |
| Sequence Alignment | 3 | 2018 | 2109 | 0.33 | Why? |
| Mice, SCID | 2 | 2017 | 225 | 0.33 | Why? |
| Viral Envelope Proteins | 2 | 2018 | 3539 | 0.33 | Why? |
| Antibodies, Monoclonal | 10 | 2021 | 8041 | 0.32 | Why? |
| Protein Conformation | 5 | 2021 | 4386 | 0.31 | Why? |
| HEK293 Cells | 6 | 2018 | 8394 | 0.29 | Why? |
| Phospholipases A | 1 | 2004 | 3 | 0.29 | Why? |
| Yolk Sac | 1 | 2004 | 2 | 0.29 | Why? |
| Protein Domains | 6 | 2021 | 6563 | 0.28 | Why? |
| Antibodies, Viral | 12 | 2021 | 51949 | 0.27 | Why? |
| Protein Multimerization | 3 | 2021 | 1336 | 0.26 | Why? |
| Crystallography, X-Ray | 4 | 2021 | 2689 | 0.26 | Why? |
| Glycosylation | 2 | 2018 | 1255 | 0.26 | Why? |
| Evolution, Molecular | 1 | 2016 | 3691 | 0.24 | Why? |
| Immunity, Maternally-Acquired | 1 | 2004 | 179 | 0.24 | Why? |
| Histocompatibility Antigens Class I | 1 | 2006 | 624 | 0.23 | Why? |
| Immunity, Mucosal | 2 | 2021 | 426 | 0.21 | Why? |
| Protein Binding | 6 | 2021 | 11430 | 0.21 | Why? |
| Animals | 17 | 2021 | 78931 | 0.21 | Why? |
| Binding Sites, Antibody | 2 | 2018 | 466 | 0.21 | Why? |
| Binding Sites | 4 | 2021 | 6201 | 0.20 | Why? |
| Mutation | 6 | 2021 | 12376 | 0.20 | Why? |
| Virus Internalization | 1 | 2018 | 7921 | 0.20 | Why? |
| Electron Spin Resonance Spectroscopy | 1 | 2018 | 14 | 0.19 | Why? |
| Antibodies, Bispecific | 1 | 2021 | 207 | 0.19 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.19 | Why? |
| Immunoglobulins | 1 | 2004 | 811 | 0.18 | Why? |
| Molecular Biology | 1 | 2021 | 139 | 0.18 | Why? |
| Neutralization Tests | 6 | 2021 | 6698 | 0.18 | Why? |
| X-Ray Diffraction | 1 | 2018 | 249 | 0.18 | Why? |
| Schizosaccharomyces pombe Proteins | 1 | 2017 | 3 | 0.18 | Why? |
| Disulfides | 1 | 2018 | 161 | 0.17 | Why? |
| Sequence Analysis, Protein | 1 | 2018 | 309 | 0.17 | Why? |
| Schizosaccharomyces | 1 | 2017 | 9 | 0.17 | Why? |
| Animal Structures | 1 | 2017 | 61 | 0.17 | Why? |
| Cell Line | 4 | 2020 | 12040 | 0.17 | Why? |
| Nuclear Envelope | 1 | 2017 | 17 | 0.17 | Why? |
| Molecular Conformation | 1 | 2018 | 374 | 0.17 | Why? |
| Endosomal Sorting Complexes Required for Transport | 1 | 2017 | 67 | 0.17 | Why? |
| HLA-B27 Antigen | 1 | 2017 | 48 | 0.17 | Why? |
| Lymphoid Tissue | 1 | 2017 | 162 | 0.16 | Why? |
| Chromatography, Gel | 1 | 2016 | 71 | 0.16 | Why? |
| Fluorescence Resonance Energy Transfer | 1 | 2018 | 320 | 0.16 | Why? |
| Virus Latency | 1 | 2018 | 251 | 0.16 | Why? |
| Amino Acid Sequence | 3 | 2016 | 6049 | 0.16 | Why? |
| Immune Sera | 1 | 2021 | 884 | 0.16 | Why? |
| Antibody Affinity | 1 | 2021 | 1078 | 0.16 | Why? |
| Testis | 1 | 2021 | 566 | 0.15 | Why? |
| HLA-B Antigens | 1 | 2017 | 166 | 0.15 | Why? |
| Viremia | 3 | 2018 | 1020 | 0.15 | Why? |
| Myeloid Cells | 1 | 2020 | 808 | 0.15 | Why? |
| Epitope Mapping | 1 | 2020 | 1240 | 0.14 | Why? |
| B-Lymphocytes | 5 | 2021 | 4418 | 0.14 | Why? |
| Nuclear Proteins | 1 | 2017 | 321 | 0.14 | Why? |
| Surface Plasmon Resonance | 1 | 2016 | 440 | 0.13 | Why? |
| Cricetinae | 2 | 2020 | 3344 | 0.13 | Why? |
| Molecular Sequence Data | 2 | 2013 | 3198 | 0.13 | Why? |
| New York | 1 | 2021 | 2488 | 0.13 | Why? |
| Intestinal Mucosa | 1 | 2021 | 1046 | 0.12 | Why? |
| Recombinant Proteins | 2 | 2020 | 3786 | 0.12 | Why? |
| Body Fluids | 1 | 2017 | 451 | 0.12 | Why? |
| Base Sequence | 2 | 2018 | 3581 | 0.11 | Why? |
| Mice | 6 | 2021 | 21357 | 0.11 | Why? |
| Longitudinal Studies | 2 | 2017 | 9893 | 0.11 | Why? |
| Immunization | 1 | 2021 | 2019 | 0.11 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 7868 | 0.10 | Why? |
| Humans | 31 | 2021 | 930598 | 0.10 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.10 | Why? |
| Software | 1 | 2021 | 2501 | 0.10 | Why? |
| Virion | 1 | 2017 | 1444 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Betacoronavirus | 3 | 2021 | 204454 | 0.09 | Why? |
| Immunologic Memory | 4 | 2021 | 3362 | 0.08 | Why? |
| Host-Pathogen Interactions | 3 | 2021 | 11041 | 0.08 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.08 | Why? |
| Drug Design | 1 | 2018 | 2627 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Gastrointestinal Diseases | 1 | 2021 | 2580 | 0.07 | Why? |
| Virus Replication | 3 | 2021 | 14331 | 0.07 | Why? |
| Phylogeny | 2 | 2021 | 13341 | 0.07 | Why? |
| Blotting, Northern | 1 | 2004 | 51 | 0.07 | Why? |
| Phospholipases A2 | 1 | 2004 | 33 | 0.07 | Why? |
| Protein Transport | 1 | 2006 | 487 | 0.07 | Why? |
| Antibody Specificity | 2 | 2020 | 1328 | 0.07 | Why? |
| Brain | 1 | 2021 | 5133 | 0.07 | Why? |
| Chick Embryo | 1 | 2004 | 249 | 0.07 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.07 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.06 | Why? |
| Epitopes, B-Lymphocyte | 2 | 2021 | 1267 | 0.06 | Why? |
| Mice, Transgenic | 2 | 2021 | 2739 | 0.06 | Why? |
| Lung | 2 | 2021 | 31049 | 0.06 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.06 | Why? |
| Biohazard Release | 1 | 2021 | 54 | 0.06 | Why? |
| Ligands | 1 | 2006 | 1300 | 0.06 | Why? |
| Directed Molecular Evolution | 1 | 2020 | 81 | 0.05 | Why? |
| Linoleic Acid | 1 | 2021 | 65 | 0.05 | Why? |
| Immune Evasion | 2 | 2021 | 2081 | 0.05 | Why? |
| Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 283 | 0.05 | Why? |
| Immunoglobulin Variable Region | 1 | 2021 | 253 | 0.05 | Why? |
| Dependovirus | 1 | 2021 | 272 | 0.05 | Why? |
| Cells, Cultured | 2 | 2021 | 5835 | 0.05 | Why? |
| Protein Structure, Quaternary | 1 | 2021 | 455 | 0.05 | Why? |
| Luciferases | 1 | 2021 | 378 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2021 | 616 | 0.05 | Why? |
| Historically Controlled Study | 1 | 2018 | 71 | 0.05 | Why? |
| HIV Envelope Protein gp160 | 1 | 2018 | 33 | 0.05 | Why? |
| Antigen-Antibody Complex | 1 | 2021 | 408 | 0.05 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.05 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.05 | Why? |
| Dogs | 1 | 2006 | 2529 | 0.05 | Why? |
| Rats | 1 | 2006 | 2764 | 0.05 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.04 | Why? |
| Vaccines | 1 | 2017 | 3692 | 0.04 | Why? |
| Microscopy, Electron | 1 | 2020 | 830 | 0.04 | Why? |
| Time-Lapse Imaging | 1 | 2017 | 28 | 0.04 | Why? |
| Mutagenesis, Site-Directed | 1 | 2018 | 449 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Mitosis | 1 | 2017 | 43 | 0.04 | Why? |
| Viral Load | 4 | 2021 | 15850 | 0.04 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2021 | 253789 | 0.04 | Why? |
| Protein Engineering | 1 | 2020 | 536 | 0.04 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2021 | 691 | 0.04 | Why? |
| Cell- and Tissue-Based Therapy | 1 | 2021 | 422 | 0.04 | Why? |
| Databases, Protein | 1 | 2021 | 523 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Microscopy, Fluorescence | 1 | 2017 | 335 | 0.04 | Why? |
| Luminescent Measurements | 1 | 2021 | 924 | 0.04 | Why? |
| Female | 10 | 2021 | 380317 | 0.04 | Why? |
| HLA Antigens | 1 | 2021 | 830 | 0.04 | Why? |
| Vaccinia virus | 1 | 2017 | 346 | 0.04 | Why? |
| Body Weight | 1 | 2021 | 1074 | 0.04 | Why? |
| Structure-Activity Relationship | 1 | 2021 | 2219 | 0.03 | Why? |
| Intestines | 1 | 2021 | 817 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.03 | Why? |
| Virulence | 1 | 2021 | 2172 | 0.03 | Why? |
| Virus Activation | 1 | 2018 | 480 | 0.03 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| HeLa Cells | 1 | 2017 | 1303 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.03 | Why? |
| Sequence Deletion | 1 | 2017 | 674 | 0.03 | Why? |
| Cytomegalovirus | 1 | 2017 | 600 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2018 | 1083 | 0.03 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.03 | Why? |
| Respiratory Mucosa | 1 | 2020 | 1522 | 0.03 | Why? |
| Biopsy | 1 | 2021 | 2811 | 0.03 | Why? |
| CD4 Lymphocyte Count | 1 | 2017 | 1517 | 0.03 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.03 | Why? |
| Male | 9 | 2021 | 367725 | 0.03 | Why? |
| Mice, Inbred C57BL | 1 | 2021 | 5542 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
| Gene Expression Profiling | 1 | 2021 | 3788 | 0.02 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| Viral Vaccines | 2 | 2021 | 7560 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2004 | 6740 | 0.02 | Why? |
| Mexico | 1 | 2017 | 2787 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.02 | Why? |
| World Health Organization | 1 | 2021 | 4213 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.02 | Why? |
| New York City | 1 | 2021 | 7432 | 0.02 | Why? |
| Aged | 5 | 2021 | 215776 | 0.02 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.02 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.02 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Computational Biology | 1 | 2021 | 4514 | 0.02 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Adult | 5 | 2021 | 244371 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Neutrophils | 1 | 2020 | 5476 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.01 | Why? |
| Brazil | 1 | 2017 | 12582 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 9335 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| RNA, Viral | 1 | 2017 | 32276 | 0.01 | Why? |
Bjorkman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(221)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(376)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_